Chesapeake Partners Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Chesapeake Partners Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-429,609	Closed	-$74.2M	–	141
2015 Q1	$74.2M	Buy	429,609 +259,569	+153%	+$38.1M	3.41%	3
2014 Q4	$19.5M	Buy	170,040 +40,040	+31%	+$4.85M	0.75%	54
2014 Q3	$20.3M	Buy	+130,000	New	+$18.8M	0.75%	49

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Chesapeake Partners Management's SLXP Position: Q2 2015 in Review

Chesapeake Partners Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 429,609 shares — an estimated $74.2M sold.

Chesapeake Partners Management first reported a position in SLXP in Q3 2014 and held it in 3 quarters. The position peaked at $74.2M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Chesapeake Partners Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Chesapeake Partners Management sold 429,609 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $74.2M.
Chesapeake Partners Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2014 and held it in 3 quarters.
Chesapeake Partners Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $74.2M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Chesapeake Partners Management's 13F filing for Q2 2015, filed 14 Aug 2015.